Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06552000
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-09
Brief Title:
Pre-operative Tumor Treating Fields in Patients With Resectable Lung Cancer
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Phase 0 Trial of Pre-operative Tumor Treating Fields in Patients With Resectable Lung Cancer
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to study the clinical and biologic effects of Tumor Treatment Fields TTFields in patients undergoing resection of stage I-IIIA Non-Small Cell Lung Cancer NSCLC TTField is a non-invasive treatment that uses low-intensity electrical fields to treat cancer Resection is the medical term for surgically removing part or all of a tissue structure or organ
Detailed Description:
To study the clinical and biologic effects of Tumor Treatment Fields TTFields in patients undergoing resection of stage I-IIIA NSCLC
Participants in this study will have a blood sample collected as well as vital signs along with a tumor tissue sample and tumor scan Once it has been determined the participant can enroll into this study heshe will come to the clinic for 5 scheduled visits over a period of 2 months
Participants in this study will have a blood sample collected as well as vital signs along with a tumor tissue sample and tumor scan Once it has been determined the participant can enroll into this study heshe will come to the clinic for 5 scheduled visits over a period of 2 months
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None